Dietary Supplement Research Centers: Botanicals RFA OD-04-002 Applicant Information Meeting February 6, 2004 Bethesda MD Christine A. Swanson, Ph.D. Office.

Slides:



Advertisements
Similar presentations
How to Build a Productive Relationship with NIH Topics Know your disease Know the NIH and NINDS Have realistic expectations Advocate for stronger NIH and.
Advertisements

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
NIGMS Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be.
Ontario Problem Gambling Research Centre April 1, 2010.
Pilot Project Program Perry Halushka MD. PhD. – Program Director Tony Alberg PhD. MPH. – Associate Program Director Randal Davis – Project Director Dayan.
Navigating the NIH Web Site for Funding and Getting Started with Grants Grants-For-Lunch December 6, 2005.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
Funding Opportunities at the Institute of Education Sciences: Information for the Grants Administrator Elizabeth R. Albro, Ph.D. Acting Commissioner National.
NIH Brown Bag Lunch SOT 2010 March 9, 2010 Janice Allen, PhD Michael Humble, PhD Division of Extramural Research and Training (DERT) National Institute.
Special Topics in IND Regulation
Funding Research Programs instead of Individual Projects Increase the stability of funding to enhance investigators’ willingness to take on ambitious scientific.
National Institute on Aging Richard J. Hodes, M.D. Director,NIA/NIH/DHHS ADC Meeting – NIH Roadmap and Budget October 2003.
EXPLORING FUNDING STRATEGIES FOR MEDICAL EDUCATION RESEARCH Christy Boscardin, PhD Bridget O’Brien, PhD Expert Panel: Sandrijn Van Schaik, MD, PhD Karen.
The NIH Roadmap for Medical Research
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
Kathryn Camp, M.S., R.D., CSP Consultant to the Office of Dietary Supplements National Institutes of Health Secretary’s Advisory Committee on Heritable.
TYPE 2 TRANSLATIONAL RESEARCH 2009 GRANT PROGRAMS UW Institute for Clinical and Translational Research (ICTR) Community-Academic Partnership Core (CAP)
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
NIH Roadmap for Medical Research and Common Fund Update on Recent Changes Dinah Singer, Ph.D. Director, Division of Cancer Biology June 18, 2008.
1 The Prevention Research Centers Program: The Case for Networks Eduardo Simoes, MD, MSc, MPH Program Director Prevention Research Centers National Center.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know! Presenter: Miriam F. Kelty, PhD, National Institute on Aging,
Responsible Conduct of Research (RCR) What is RCR? New Requirements for RCR Who Does it Affect? When? Data Management What is the Institutional Plan? What.
The Role of Research in Osteopathic Medical Education American Association of Colleges of Osteopathic Medicine June 25, 2004 David B. Moore Associate Vice.
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
Research Program Overview National Institute on Disability and Rehabilitation Research Robert J. Jaeger, Ph.D. Interagency and International Affairs Interagency.
Academic Research Enhancement Award (AREA) Program Erica Brown, PhD Director, NIH AREA Program National Institutes of Health 1.
VICTR Funding Overview Vanderbilt Institute for Clinical and Translational Research (VICTR) June 22, 2012.
DIABETES AND SCIENCE EDUCATION IN AMERICAN INDIAN SCHOOLS: Time Line Lawrence Agodoa, M.D. Director, Office of Minority Health Research Coordination National.
AHRQ 2011 Annual Conference: Insights from the AHRQ Peer Review Process Training Grant Review Perspective Denise G. Tate Ph.D., Professor, Chair HCRT Study.
Systematic Review of Dietary Supplement Efficacy and Safety Paul M. Coates, Ph.D. Office of Dietary Supplements National Institutes of Health Department.
Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.
Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4) RFA OD Pre-application workshop October 23, 2009.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Discovery: Stem Cell Biology Proposed Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
1 Academic Research Enhancement Award (AREA) Program Erica Brown, PhD NIH AREA Program Director NIH Regional Seminar Scottsdale, Arizona April 28, 2011.
1 Preparing an NIH Institutional Training Grant Application Rod Ulane, Ph.D. NIH Research Training Officer Office of Extramural Research, NIH.
1 Judy Hewitt, PhD On Detail to Office of Extramural Research National Institutes of Health May 18, 2015 Center for Scientific Review Advisory Council.
National Institute of Biomedical Imaging and Bioengineering Richard E. Swaja, Ph.D. National Institute of Biomedical Imaging and Bioengineering BERAC –
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
NOAA Cooperative Institutes John Cortinas, Ph.D. OAR Cooperative Institute Program, Program Manager NOAA Cooperative Institute Committee, Chairperson.
Inclusion of Women in Clinical Trials & Drug Development Regulatory Perspective Ameeta Parekh, Ph.D. R&D Director Office of Women’s Health Food & Drug.
Group Science J. Marc Overhage MD, PhD Regenstrief Institute Indiana University School of Medicine.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
REPORT OF THE NAGMS COUNCIL MORE DIVISION WORKING GROUP Charge to the Group The National Advisory General Medical Sciences (NAGMS) Council MORE Division.
Atlantic Innovation Fund Round VIII February 5, 2008.
National Institutes of Health U.S. Department of Health and Human Services Superfund Research Program (R13) Alicia V. Lawson, MPH Health Specialist NIEHS.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care The “Centers for Education & Research on Therapeutics” (CERTs)
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
NIAMS Training Grant and Career Development Award Program Evaluation Presented by David Wofsy, M.D. Chairman Evaluation Working Group September 27, 2007.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
National Institutes of Health U.S. Department of Health and Human Services Recipe for an RFA (Request for Applications) Danielle J. Carlin, PhD, DABT Program.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
Institutional Development Award (IDeA) Program – Infrastructure for Clinical and Translational Research (IDeA-CTR) J. Rafael Gorospe M.D. Ph.D. Medical.
Funding Opportunities at the Institute of Education Sciences Elizabeth R. Albro, Ph.D. Teaching and Learning Division National Center for Education Research.
Research Directions and Update from the NIA Basil Eldadah Division of Geriatrics and Clinical Gerontology NIA.
Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.
University Career Services Committee
Center for Childhood Obesity Prevention
Grant Writing Information Session
Bozeman Health Clinical Research
Rick McGee, PhD and Bill Lowe, MD Faculty Affairs and NUCATS
UNCFSP/NLM HBCU ACCESS Project
Professional Organizations
Clinical and Translational Science Awards Program
National Pediatric Critical Care Collaborative Research Network
Presentation transcript:

Dietary Supplement Research Centers: Botanicals RFA OD Applicant Information Meeting February 6, 2004 Bethesda MD Christine A. Swanson, Ph.D. Office of Dietary Supplements, NIH

Overview  Dietary Supplement Research Centers  Botanical Research Center Program  Expert Panel Review  NIH Presentation to Panel  Panel Recommendations  RFA OD  New Features  Guidance Documents

Congressional Mandate (FY 1999) “ establish a botanical research initiative with major research institutions in the United States”

Dietary Supplement Research Centers: Botanicals Awards: University of California Los AngelesUniversity of California Los Angeles University of Illinois at ChicagoUniversity of Illinois at Chicago University of ArizonaUniversity of Arizona Purdue University/University of AlabamaPurdue University/University of Alabama University of MissouriUniversity of Missouri Iowa State University/University of IowaIowa State University/University of Iowa Budget: $ Million/Year for 5 Years Awarding Organizations: ODS, NCCAM, NIEHSODS, NCCAM, NIEHS Additional support from NIGMS, ORWHAdditional support from NIGMS, ORWH

Presentation to Expert Panel February 21, 2003 Presentation to Expert Panel February 21, 2003

Botanical Research Centers Program Purpose: To establish Specialized Research Centers to investigate the biological effects of botanicals, including those available as ingredients in dietary supplements

Goals  To foster interdisciplinary research to promote rigorous scientific study of botanicals  To explore the potential of botanicals (dietary supplements) to improve health care  To develop models to evaluate the efficacy and safety of botanicals* * Modified in RFA OD

Spectrum of Research Activities (Major Areas of Emphasis)  Identify and characterize botanicals  Assess bioavailability and bioactivity  Identify active constituent(s) and explore mechanism(s) of action  Conduct clinical research

Required Elements  Institutional Commitment  Administrative Core  Two Research Cores  Botanical Core Required *  Three to Four Research Projects  Pilot Research Program  Training and Career Development *  Consumer Information * * Modified in RFA OD

AdministrativeCore Research Projects P1P2P3 RC 2 RC 3 Resource Cores RC 1

Lessons Learned  RFA  Required Elements Clearly Identified  The Grant Application  Scientific Merit (R01 Projects)  Research Experience of Investigators  Research Resources (Contemporary)  Collaborative Effort (Synergy)  Administrative Oversight  Administrative Core of Research Center  External Advisory Committee  NIH Program Staff

Questions to Expert Panel  Research Theme  Focus  Center Structure  Cores (Botany ?)  Synergy/Collaboration  Productivity  Criteria

Expert Panel Recommendations High-impact theme Studies of basic mechanisms and human health, with a high level of translational interaction between the two Innovative Technology * Emphasis on quality assurance/quality control

Guidance Document NCCAM Policy on the Quality of Natural Products Research (see RFA)

RFA OD Dietary Supplement Research Centers: Botanicals

RFA OD Developed in Collaboration with NIH Offices, Centers and Institutes (ODS, NCCAM, NIEHS) * Important Dates Letter of Intent Receipt Date: May 18, 2004 Letter of Intent Receipt Date: May 18, 2004 Application Receipt Date: June 15, 2004 Application Receipt Date: June 15, 2004 Peer Review Date: October/November 2004 Peer Review Date: October/November 2004 Council Review: January 2005 Council Review: January 2005 Earliest Anticipated Start Date: April 2005 Earliest Anticipated Start Date: April 2005 * Other ICs may participate

Botanical (Definition) For the purpose of this RFA, “botanical” is defined as plants, plant parts (e.g., bark, leaves, stems, roots, flowers, fruits, seeds, berries), plant exudates, algae, and macroscopic fungus. The definition of “botanical” is further extended to include botanical extracts and isolated bioactive constituents other than essential nutrients.

Examples of Botanical Ingredients in Dietary Supplements Phytomedicines Phytomedicines St. John’s Wort, Valerian, Ginkgo St. John’s Wort, Valerian, Ginkgo Foods Foods Soy, Garlic, Green Tea, Blueberry Soy, Garlic, Green Tea, Blueberry

Bacterial or yeast fermentation products are not included. Synthetic compounds derived from botanical sources are not encouraged as test materials for research conducted under this initiative. If the applicant proposes to study synthetic compounds, their use must be scientifically justified. This RFA is not supportive of applications aimed at new drug discovery. Excluded test materials

Botanical Ingredients: Foods or Drugs ( Intended Use) 1. FDA Regulation: Dietary supplements are not intended to diagnose, cure, mitigate, treat or prevent disease. 2. NIH recognizes FDA regulations but research on botanicals, for the purpose of this RFA, is not necessarily bounded by the above constraints.

Frequently Asked Questions

Rationale for Selection of 1.Test materials 2.Biological Process 3.Health Outcomes 4. Theme

RFA OD Purpose  Promote interdisciplinary collaborative study of botanicals, particularly those that are found as ingredients in dietary supplements  Conduct research of high potential for being translated into practical benefits for human health

RFA OD Objectives 1. Build collaborative research teams to advance the basic science to inform clinical studies:  Characterize chemical composition of botanicals and study biological effects to provide better predictions of safety and efficacy in humans  Expand research base with development and improvement of preclinical model systems

RFA OD Objectives 2. Cultivate the use of contemporary technologies and innovative approaches 3. Conduct Clinical Studies (optional)

Clinical Studies  Optional  Phase I or early Phase II  NCCAM Requirement: Review of Funded Projects (OCRA)  NCCAM Guidance Document (see RFA)  IND Clearance  Is an IND Required?  Questions addressed to FDA  See RFA for FDA contact